HIGHLIGHTS
- who: Derek Essegian from the Miller School University of Miami, Miami, USA have published the Article: The Clinical Kinase Index: A Method to Prioritize Understudied Kinases as Drug Targets for the Treatment of Cancer, in the Journal: (JOURNAL) of October/20,/2020
- what: Collectively the authors report that understudied kinases have potential clinical value as biomarkers or drug targets that warrant further study. In the analysis , 357 kinases were shown to be prognostic of M-stage, 522 for N-stage, and 552 for T-stage. The authors systematically integrated DGE, KM survival, and mutational hotspot . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.